Mark G. Foletta's Insider Trades & SAST Disclosures
Mark G. Foletta's most recent trade in Dexcom Inc was a trade of 5,731 Common Stock done . Disclosure was reported to the exchange on May 8, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark G. Foletta.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dexcom Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 5,731 | 5,731 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2025 | 2,973 | 59,371 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 May 2025 | 2,973 | 0 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 8,325 | 8,325 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2025 | 3,019 | 0 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2025 | 3,019 | 13,273 (0%) | 0% | 0 | Common Stock | |
| Enanta Pharmaceuticals Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 15,700 | 15,700 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 116.75 per share. | 17 Jun 2024 | 3,007 | 56,697 (0%) | 0% | 116.7 | 351,065 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 117.16 per share. | 17 Jun 2024 | 2,212 | 60,179 (0%) | 0% | 117.2 | 259,159 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 117.77 per share. | 17 Jun 2024 | 475 | 59,704 (0%) | 0% | 117.8 | 55,942 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 117.24 per share. | 17 Jun 2024 | 299 | 56,398 (0%) | 0% | 117.2 | 35,056 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 115.14 per share. | 17 Jun 2024 | 7 | 62,391 (0%) | 0% | 115.1 | 806 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 2,973 | 2,973 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2024 | 3,306 | 62,398 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2024 | 3,306 | 0 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2024 | 3,019 | 3,019 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 1,681 | 0 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 1,681 | 10,254 (0%) | 0% | 0 | Common Stock | |
| Enanta Pharmaceuticals Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 15,700 | 15,700 | - | - | Stock Option (right to buy) | |
| AMN Healthcare Services Inc. | G. Mark Foletta | Director | Purchase of securities on an exchange or from another person at price $ 56.90 per share. | 29 Feb 2024 | 500 | 8,573 (0%) | 0% | 56.9 | 28,450 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2023 | 4,488 | 59,092 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2023 | 4,488 | 3,306 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 3,306 | 7,794 (0%) | 0% | 0.0 | 3 | Common Stock |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,681 | 1,681 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 88.78 per share. | 21 Apr 2023 | 1,458 | 8,073 (0%) | 0% | 88.8 | 129,441 | Common Stock |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 1,458 | 9,531 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 1,458 | 0 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 84.29 per share. | 11 Apr 2023 | 4,989 | 9,126 (0%) | 0% | 84.3 | 420,523 | Common Stock |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 84.63 per share. | 11 Apr 2023 | 1,053 | 8,073 (0%) | 0% | 84.6 | 89,115 | Common Stock |
| Enanta Pharmaceuticals Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 10,800 | 10,800 | - | - | Stock Option (right to buy) | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2022 | 300 | 14,115 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 1,122 | 1,122 (0%) | 0% | 0.0 | 1 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 1,054 | 0 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 1,054 | 13,651 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 2,139 | 14,415 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 2,139 | 0 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2022 | 1,458 | 1,458 | - | - | Restricted Stock Units | |
| Enanta Pharmaceuticals Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 562.78 per share. | 01 Dec 2021 | 116 | 12,792 (0%) | 0% | 562.8 | 65,283 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 565.52 per share. | 01 Dec 2021 | 87 | 12,640 (0%) | 0% | 565.5 | 49,200 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 561.85 per share. | 01 Dec 2021 | 78 | 12,908 (0%) | 0% | 561.8 | 43,824 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 558.79 per share. | 01 Dec 2021 | 70 | 12,986 (0%) | 0% | 558.8 | 39,115 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 564.23 per share. | 01 Dec 2021 | 65 | 12,727 (0%) | 0% | 564.2 | 36,675 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 556.88 per share. | 01 Dec 2021 | 41 | 13,056 (0%) | 0% | 556.9 | 22,832 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 569.54 per share. | 01 Dec 2021 | 41 | 12,597 (0%) | 0% | 569.5 | 23,351 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 567.50 per share. | 01 Dec 2021 | 2 | 12,638 (0%) | 0% | 567.5 | 1,135 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 625.32 per share. | 01 Nov 2021 | 124 | 13,358 (0%) | 0% | 625.3 | 77,540 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 628.41 per share. | 01 Nov 2021 | 76 | 13,219 (0%) | 0% | 628.4 | 47,759 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 627.79 per share. | 01 Nov 2021 | 56 | 13,295 (0%) | 0% | 627.8 | 35,156 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 615.13 per share. | 01 Nov 2021 | 45 | 13,552 (0%) | 0% | 615.1 | 27,681 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 624.09 per share. | 01 Nov 2021 | 43 | 13,482 (0%) | 0% | 624.1 | 26,836 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 629.33 per share. | 01 Nov 2021 | 42 | 13,177 (0%) | 0% | 629.3 | 26,432 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 634.00 per share. | 01 Nov 2021 | 40 | 13,097 (0%) | 0% | 634 | 25,360 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 631.25 per share. | 01 Nov 2021 | 40 | 13,137 (0%) | 0% | 631.3 | 25,250 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 619.29 per share. | 01 Nov 2021 | 14 | 13,538 (0%) | 0% | 619.3 | 8,670 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 622.62 per share. | 01 Nov 2021 | 13 | 13,525 (0%) | 0% | 622.6 | 8,094 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 626.00 per share. | 01 Nov 2021 | 7 | 13,351 (0%) | 0% | 626 | 4,382 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 544.39 per share. | 01 Oct 2021 | 181 | 13,649 (0%) | 0% | 544.4 | 98,535 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 543.15 per share. | 01 Oct 2021 | 126 | 13,830 (0%) | 0% | 543.2 | 68,437 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 540.93 per share. | 01 Oct 2021 | 88 | 13,956 (0%) | 0% | 540.9 | 47,602 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 547.06 per share. | 01 Oct 2021 | 51 | 13,598 (0%) | 0% | 547.1 | 27,900 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 538.02 per share. | 01 Oct 2021 | 47 | 14,050 (0%) | 0% | 538.0 | 25,287 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 539.17 per share. | 01 Oct 2021 | 6 | 14,044 (0%) | 0% | 539.2 | 3,235 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 552.00 per share. | 01 Oct 2021 | 1 | 13,597 (0%) | 0% | 552 | 552 | Common Stock |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 11 Jun 2021 | 2,500 | 12,276 (0%) | 0% | 95.0 | 237,540 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 1,054 | 1,054 (0%) | 0% | 0.0 | 1 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2021 | 895 | 14,097 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2021 | 895 | 0 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 2,826 | 0 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 2,826 | 14,776 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc. | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 2,139 | 2,139 | - | - | Restricted Stock Units | |
| Enanta Pharmaceuticals Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 341.79 per share. | 16 Nov 2020 | 428 | 13,503 (0%) | 0% | 341.8 | 146,284 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 342.93 per share. | 16 Nov 2020 | 301 | 13,202 (0%) | 0% | 342.9 | 103,222 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 337.78 per share. | 16 Nov 2020 | 139 | 14,048 (0%) | 0% | 337.8 | 46,951 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 340.23 per share. | 16 Nov 2020 | 117 | 13,931 (0%) | 0% | 340.2 | 39,807 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 337.00 per share. | 16 Nov 2020 | 15 | 14,187 (0%) | 0% | 337 | 5,055 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 397.41 per share. | 15 Oct 2020 | 375 | 14,410 (0%) | 0% | 397.4 | 149,030 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 396.51 per share. | 15 Oct 2020 | 255 | 14,785 (0%) | 0% | 396.5 | 101,109 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 398.25 per share. | 15 Oct 2020 | 208 | 14,202 (0%) | 0% | 398.2 | 82,835 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 395.02 per share. | 15 Oct 2020 | 120 | 15,040 (0%) | 0% | 395.0 | 47,402 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 391.48 per share. | 15 Oct 2020 | 42 | 15,160 (0%) | 0% | 391.5 | 16,442 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 393.73 per share. | 14 Sep 2020 | 231 | 15,659 (0%) | 0% | 393.7 | 90,951 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 395.28 per share. | 14 Sep 2020 | 222 | 15,437 (0%) | 0% | 395.3 | 87,753 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 391.95 per share. | 14 Sep 2020 | 200 | 15,890 (0%) | 0% | 392.0 | 78,390 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 396.17 per share. | 14 Sep 2020 | 121 | 15,316 (0%) | 0% | 396.2 | 47,936 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 397.75 per share. | 14 Sep 2020 | 114 | 15,202 (0%) | 0% | 397.8 | 45,344 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 390.86 per share. | 14 Sep 2020 | 109 | 16,090 (0%) | 0% | 390.9 | 42,604 | Common Stock |
| Dexcom Inc | Mark G. Foletta | Director | Sale of securities on an exchange or to another person at price $ 386.33 per share. | 14 Sep 2020 | 3 | 16,199 (0%) | 0% | 386.3 | 1,159 | Common Stock |
| Enanta Pharmaceuticals Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2020 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Dexcom Inc | Mark G. Foletta | Director | Other type of transaction at price $ 0.00 per share. | 22 May 2020 | 3,055 | 16,202 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Other type of transaction at price $ 0.00 per share. | 22 May 2020 | 3,055 | 0 (0%) | 0% | 0 | Common Stock | |
| Dexcom Inc | Mark G. Foletta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2020 | 895 | 895 (0%) | 0% | 0.0 | 1 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges